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Abstract
The dietary intake of essential nutrients and bioactive food compounds is a pro-
cess that occurs on a daily basis for the entire life span. Therefore, your diet has a 
great potential to cause changes in the epigenome. Known histone modifications 
include acetylation, methylation, biotinylation, poly(ADP-ribosylation), ubiquiti-
nation, and sumoylation. Some of these modifications depend directly on dietary 
nutrients. For other modifications, bioactive dietary compounds may alter the ac-
tivities of enzymes that establish or remove histone marks, thereby altering the 
epigenome. This chapter provides an overview of diet-dependent epigenomic 
marks in histones and their links with human health.
Keywords: Bioactive food compounds, diet, epigenome, minerals, nutrition, 
vitamins 
Abbreviations: 
Avy   Viable yellow agouti
CoA   Coenzyme A
DNMT1   DNA methyltransferase 1
FAD   Flavin adenine dinucleotide
H3K4me3  K4-trimethylated histone H3
H3K9ac   K9-acetylated histone H3
H3K9me2  K9-dimethylated histone H3
H3K9me3  K9-trimethylated histone H3
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H4K5ac   K5-acetylated histone H4
H4K8ac   K8-acetylated histone K12
H4K12ac  K12-acetylated histone H4
H4K12bio  K12-biotinylated histone
H4H4K16ac  K16-acetylated histone H4
H4K20me3  K20-trimethylated histone H4
HAT   Histone acetyl transferase
HDAC   Histone deacetylase
HLCS   Holocarboxylase synthetase
HMT   Histone methyl transferase
JmjC   Jumonji C
K   Lysine
LSD1   Lysine-specific demethylase 1
SET   Suppressor of variegation enhancer of zeste trithorax
Sir2   Silent information regulator 2
1 Introduction
The human epigenome is constantly exposed to a variety of environmental 
factors that may alter chromatin structure, gene regulation, genome stabil-
ity, and an individual’s predisposition to disease. Frequently, individuals are 
exposed to these factors in a controlled environment over a short period of 
time in subsets of the general population. The treatment of cancer patients 
with the histone deacetylase inhibitor, belinostat (Ma et al. 2010), and lifestyle 
choices such as smoking are examples (Launay et al. 2009). This is not the 
case for human nutrition.
The dietary intake of essential nutrients and bioactive food compounds is 
a process that occurs on a daily basis for the entire life span. Therefore, it has 
great potential for causing changes in both the epigenome and disease risk. A 
well-documented example is the feeding of defined diets to agouti mice, where 
dietary supplementation with methyl donors and genistein resulted in in-
creased DNA methylation of a long terminal repeat in the viable yellow agouti 
(Avy ) locus and an alteration in offspring coat color and disease susceptibil-
ity in adulthood (Cooney et al. 2002; Dolinoy et al. 2006; Waterland and Jirtle 
2003; Wolff et al. 1998). Epidemiologic studies also indicate that adult disease 
risk is associated with poor nutritional status early in development. Individu-
als exposed to the famine during the Dutch Hunger Winter of 1944 and 1945 is 
the most widely recognized example (Heijmans et al. 2008). Put simply, dietary 
choices during pregnancy can alter the disease risk of the unborn child later in 
life. It remains to be seen whether such scenarios hold true under conditions 
that are more moderate than the Dutch Hunger Winter.
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A large number of covalent modifications have been identified in the N-ter-
mini of histones, while some modifications also exist in the hinge regions and 
the C-termini. Known modifications include acetylation, methylation, biotinyl-
ation, poly(ADP-ribosylation), ubiquitination, and sumoylation (Boulikas 1988; 
Boulikas et al. 1990; Camporeale et al. 2004; Chambon et al. 1966; Kouzarides 
and Berger 2007; Shiio and Eisenman 2003; Stanley et al. 2001; Wolffe 1998). For 
many of these modifications, unambiguous links have been established with 
human disease and nutrition.
One might consider classifying diet-dependent histone modifications ac-
cording to the following scheme. In one group of histone marks, nutrient 
supply is a limiting factor only under exceptional circumstances, but bio-
active compounds and essential nutrients in food may modulate the abun-
dance of the modification by altering enzyme activities. This group of histone 
marks would include iron-,  calcium-, and riboflavin-dependent demethyl-
ation of histones and the inhibition of histone deacetylases by sulforaphane. 
In a second group of histone marks, essential nutrients or functional groups 
thereof are attached to histones, and dietary nutrient availability can be a 
limiting factor for creating these marks. Histone methylation, biotinylation, 
and poly(ADP-ribosylation) belong in this group. In a third group of histone 
marks, specific nutrients are attached to histones, but the availability of these 
nutrients is not a limiting factor under normal circumstances. Sumoylation 
and ubiquitination belong in this group.
2 Acetylation of Histones
Histone acetylation marks are associated with transcriptionally active 
chromatin (Kouzarides and Berger 2007). Lysine (K)-9 acetylated histone H3 
(H3K9ac), H4K5ac, H4K8ac, H4K12ac, and H4K16ac are the most frequently 
studied markers for acetylation-mediated gene activation. There are two di-
etary compounds directly involved in acetylation events. The first is acetate, 
which can be derived from the metabolism of glucose, amino acids, fatty acids, 
and other compounds in intermediary metabolism (Garrett and Grisham 1995). 
Except for circumstances of prolonged total starvation, it is nearly impossible 
to deplete the body pool of acetate. The second is coenzyme A (CoA), which 
is required for generation of the energy-rich acetyl-CoA for subsequent acet-
ylation reactions. The vitamin pantothenic acid is an integral part of the CoA 
molecule (Garrett and Grisham 1995). In the most recent edition of the Dietary 
Reference Intakes, the Food and Nutrition Board acknowledges that human 
pantothenic acid requirements are unknown (National 1998). Thus, only rec-
ommendations for Adequate Intake are available for pantothenic acid. These 
recommendations are based solely on the intake of pantothenic acid in the gen-
eral, apparently healthy, population (National 1998). There is currently no com-
pelling evidence to suggest that the prevalence of pantothenic acid deficiency is 
quantitatively meaningful in Western societies; the prevalence of deficiency in 
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developing countries or in unique, small subgroups within the general popula-
tion is unknown.
Acetylation of histones is catalyzed by histone acetyl transferases (HATs) 
such as PCAF, STAGA, and TFTC, which are grouped on the basis of their cat-
alytic domains such as GCN5 and PCAF {see (Lee and Workman 2007) for an 
excellent review}. Little is known about dietary modulation of HAT activity; 
however, the dietary polyphenol curcumin is an inhibitor of the acetyl transfer-
ase p300 (Morimoto et al. 2008).
Histone deacetylases (HDACs) catalyze the enzymatic removal of acetyl 
mark from the ε-amino group of lysines in histones during gene repression 
(Minucci and Pelicci 2006). The family of HDACs comprises 18 isoforms, which 
are categorized into four classes, depending on sequence identity and domain 
organization (Table 1) (Dokmanovic et al. 2007). Histone deacetylation by class 
III HDACs (sirtuins) is coupled to NAD+ hydrolysis, which is a niacin-depen-
dent event; the dietary supply of niacin and niacin precursors is discussed be-
low. Sir2 (silent information regulator 2) in simple eukaryotes and its mamma-
lian ortholog SIRT1 play important roles in life span extension in response to 
caloric restriction (Boily et al. 2008). The efficacy of SIRT1 in enhancing the life 
span in mammals appears to depend on salvaging NAD in the nicotinamide 
phosphoribosyl transferase pathway (Ho et al. 2009a). The phenolic compound 
resveratrol activates sirtuins and increases the life span in Saccharomyces cere-
visiae, Caenorhabditis elegans, Drosophila melanogaster, and the fish Notho-
branchius furzeri, but its efficacy in mammals is uncertain (Evason et al. 2005; 
Howitz et al. 2003; Kang et al. 2002; Valenzano et al. 2006). Resveratrol is pres-
ent in grapes and red wine at relatively high concentration (Celotti et al. 1996).
Hypoacetylation of histones is a hallmark of human cancer. HDAC inhibi-
tors may induce cell cycle arrest, differentiation, and apoptosis in cancer cells. 
Thus, HDAC inhibitors are considered promising tools in the prevention and 
treatment of the disease (Liu et al. 2006), and synthetic inhibitors such as beli-
nostat are already being tested in clinical trials (Ma et al. 2010). Importantly, 
HDAC activity may be modulated by a number of dietary compounds. Sodium 
butyrate is an HDAC inhibitor that can be produced by gastrointestinal fer-
mentation of fermentable fiber, particularly resistant starch (Cummings et al. 
2001; Davie 2003). Nicotinamide is a competitive inhibitor of the class III sir-
tuins, and it may restore some of the cognitive deficits in Alzheimer’s disease 
(Green et al. 2008). Sulforaphane is an isothiocyanate found in relatively high 
concentrations in cruciferous vegetables such as broccoli and brussel sprouts. 
Table 1. Histone deacetylases
Class   Member
I   HDAC1, HDAC2, HDAC3, HDAC8
II   HDAC4, HDAC5, HDAC6, HDAC7A, HDAC9, HDAC10
III   SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, SIRT6, SIRT7
IV   HDAC11
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Although it inhibits HDACs (Ho et al. 2009b; Myzak et al. 2006), it is uncertain 
whether pharmacologically effective concentrations can be achieved through 
a normal diet. Synthetic selenium-containing analogs of suberoyl hydroxamic 
acid also show promise as HDAC inhibitors (Desai et al. 2010). The extent to 
which dietary selenium compounds affect HDAC activity is unknown.
Diseases other than cancer are also linked with acetylation events in the 
epigenome, although unambiguous cause-and-effect relationships still remain 
to be demonstrated for many of these diseases. A link to diabetes is proposed 
because of the physical interactions of the HATs p300, CBP, and PCAF with he-
patocyte nuclear factor and glucokinase (Gray and De Meyts 2005). These inter-
actions do not constitute a classical epigenetic mechanism but rather a change 
in transcription factor and enzyme activity. The abundance of histone H4 acety-
lation marks is abnormally increased in the promoters of NFκB-dependent pro-
inflammatory genes in lung diseases such as asthma and cystic fibrosis (Selvi 
and Kundu 2009). Nevertheless, the roles of HATs and HDACs and the pos-
sible modulation by dietary intervention in these diseases are far from being 
understood. Roles for histone acetylation are also proposed for neurodegen-
erative disorders, cardiac hypertrophy, and malaria; however, the underlying 
mechanisms and environmental perturbations remain to be elucidated (Freitas-
Junior et al. 2005; McKinsey and Olson 2004; Saha and Pahan 2006).
It is difficult to establish causal links between changes in acetylation marks 
in the epigenome and roles for HDACs in human health because HDACs also 
target nonhistone proteins such as transcription factors (Drummond et al. 
2005; Selvi and Kundu 2009). It also appears that both drugs and dietary com-
pounds that affect HDACs elicit off-target effects by modifying the transcrip-
tional activity of genes not related to disease. For example, evidence suggests 
that HDAC inhibitors increase the acetylation of histones in transposable ele-
ments. This is associated with their transcriptional activation (Brunmeir et al. 
2010a, b; Montoya-Durango et al. 2009), and transcriptional activation of trans-
posable elements impairs genome stability (Fan 2007; Gasior et al. 2006). More 
studies are needed to investigate aberrant gene regulation caused by these off-
target effects.
3 Methylation of Histones
Methylation events in the epigenome depend on the dietary supply of 
methyl donors and other essential cofactors. Both cytosines in DNA and 
histones are targets for methylation (Kouzarides and Berger 2007; Li and 
Bird 2007). This chapter focuses exclusively on histone epigenetic marks, 
whereas cytosine methylation is covered in other chapters in this book. The 
reader should note, however, that the histone methyl transferase (HMT) 
G9a is known to interact with DNA methyltransferase 1 (DNMT1) (Esteve 
et al. 2006). When DNMT1 is knocked down by using siRNA, both cytosine 
and H3K9 methylation on chromatin are impaired, confirming DNMT1 as 
the primary loading factor. Consistent with this notion, aberrant cytosine 
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methylation impairs both histone methylation and histone biotinylation 
(Chew et al. 2008).
Both arginine and lysine residues in histones are potential targets for meth-
ylation (Bedford and Clarke 2009; Martin and Zhang 2005). HMT activity to-
ward lysine and arginine residues is found in a family of enzymes with a con-
served catalytic domain called SET (suppressor of variegation, enhancer of 
zeste, trithorax) (Albert and Helin 2010). The human genome encodes 48 SET 
domain-containing proteins and DOT1L, which does not contain a SET domain 
but has lysine methyltransferase activity. The domain structures, phylogenetic 
tree, and histone targets of HMTs are covered in depth in an excellent recent re-
view (Albert and Helin 2010).
Histone methylation is a dynamic and reversible process. As of today, three 
classes of histone demethylases have been identified (Klose et al. 2006). The larg-
est class of demethylase enzymes contains a Jumonji C (JmjC) domain. The JmjC 
domain-containing enzymes can demethylate mono-, di-, and trimethylated his-
tones by an oxidative mechanism that requires Fe(II) and alpha-ketoglutarate 
as cofactors (Tsukada et al. 2006). The following subgroups in the general pop-
ulation are at risk for developing iron deficiency: infants (particularly prema-
ture and low-birth-weight babies), young children, menstruating and pregnant 
women, vegetarians, and people who have internal bleeding or who get kid-
ney dialysis treatment (National 2011). Nevertheless, it is unclear to what extent 
iron deficiency affects histone demethylation events. Lysine-specific demethyl-
ase 1 (LSD1) is the founding member of the second class of histone demethylases. 
Enzymes in this class demethylate only mono- or dimethylated H3K4me and 
H3K9me and depend on flavin adenine dinucleotide (FAD) as a coenzyme for 
oxidative demethylation. FAD is one of the two coenzyme forms of the vitamin 
riboflavin (Rivlin 2007). Dietary riboflavin deficiency is uncommon in developed 
countries, but deficiency may be precipitated by adrenal and thyroid hormone 
deficiency, psychotropic agents such as chlorpromazine, antidepressants such as 
imipramine and amitriptyline, chemotherapeutic drugs such as Adriamycin, and 
antimalarial agents such as quinacrine (Rivlin 2007). It is unknown whether ri-
boflavin deficiency affects histone demethylation to a meaningful extent. Pep-
tidylarginine deiminase 4 is the third class of histone demethylases, and it was 
the first to be identified. It converts methylated arginine to citrulline (as opposed 
to producing unmethylated arginine) in a Ca2+-dependent reaction (Wang et al. 
2004). It is unknown whether calcium deficiency affects histone demethylation to 
a meaningful extent. Please note that vitamin D and biotin play important roles 
in calcium homeostasis and cellular compartmentalization, respectively (Griffin 
et al. 2006; Norman and Henry 2007).
Histone methylation depends on a sufficient supply of S-adenosylmethio-
nine (SAM) as a methyl donor (Figure 1). In this reaction, a methyl group is 
transferred from SAM to histones (or other methyl acceptors) and SAM is con-
verted to S-adenosylhomocysteine (SAH). In addition to SAM, numerous other 
nutrients and metabolites also play key roles in one-carbon metabolism and, 
hence, methylation reactions {see (Bailey 2007) for an elaborate review}. Briefly, 
L-homocysteine can be remethylated to produce L-methionine in a reaction 
that depends on both 5-methyltetrahydrofolate and vitamin B12. Deficiency of 
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vitamin B12 is frequently seen in vegans, the elderly, and after surgical removal 
of the ileum. Furthermore, it leads to folate depletion by trapping the latter as 
5-methyltetrahydrofolate (Green and Miller 2007). Dietary compounds such as 
betaine and choline also play important roles in replenishing the one-carbon 
pool (Bailey 2007). Finally, zinc is a cofactor for DNMT1 (Wolff et al. 1998); im-
paired methylation of cytosines may precipitate aberrant patterns of histones 
marks, as described above.
Folate deficiency used to be relatively common in the general population 
and was blamed for being a factor contributing toward birth defects, particu-
larly neural tube defects and congenital heart defects (Bailey 2007). Many coun-
tries have adopted a policy mandating folate fortification of staple foods. These 
policies have proven effective with regard to decreasing the incidence of neural 
tube defects and, perhaps, congenital heart defects (Botto et al. 2003; Honein et 
al. 2001). Most studies of folate and birth defects have focused on abnormalities 
in cytosine methylation and impaired thymidine synthesis, with the latter lead-
ing to uracil misincorporation into DNA.
It is difficult to unambiguously attribute adverse effects of methyl defi-
ciency to distinct patterns of histone methylation for the following reasons. 
Firstly, the great number of histone methyltransferases (48 SET domain-
containing proteins and DOT1L) requires a combination of sound enzyme 
kinetics data with regard to substrate affinity and fairly advanced computer 
algorithms to predict effects of altered methyl supply on the biological ac-
tivity of individual enzymes. This information is not yet available. It is also 
important to consider possible effects of single nucleotide polymorphisms 
on substrate affinity and enzyme activity. Secondly, it is currently unclear 
to what extent betaine and choline can substitute for folate in one-carbon 
metabolism, although some mathematic models are emerging (Reed et al. 
2006). Thirdly, histone methylation marks can have opposing effects in gene 
regulation. Classical examples include H3K4me3 and H3K9me, which are 
transcriptional activation and repression marks, respectively (Kouzarides 
and Berger 2007). Thus, methyl deficiency might affect both gene activa-
tion and repression. Finally, the flow of information among marks in the 
epigenome is immense and goes far beyond a cross talk among methyla-
tion marks. Epigenomic synergies have been documented for H3K4acme3 
Figure 1. One-carbon flux. 
Abbreviations: CH 3 methyl, 
THF tetrahydrofolate. 
1. betaine: homocystein 
methyltransferase, 
2. methionine synthase, 
3. methionine 
adenosyltransferase, 
4. histone methyltransferase(s), 
5. S-adenosylhomocysteine 
hydrolase.
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and H3K9ac in gene activation (Kouzarides and Berger 2007) and for cyto-
sine methylation, H3K9me2, and H4K12bio in the repression of retrotrans-
posons (Chew et al. 2008). Despite these limitations, the following themes 
have emerged in the field of diet-dependent changes in the histone methy-
lome and their consequences for human health.
Loss of H4K16ac and H4K20me3 is a hallmark of human cancer (Fraga et 
al. 2005), and there is now consensus that aberrant methylation marks in the 
epigenome play a significant role in cancer development and progression 
(Poke et al. 2010). Evidence suggests that HATs, HDACs, and HMTs can 
act as tumor suppressor genes or oncogenes. Occasionally, these effects also 
depend on chromosomal rearrangements and the expression of fusion pro-
teins (Albert and Helin 2010; Fraga and Esteller 2005; Huang 2002). Clearly, 
the abundance of histone methylation marks depends on the dietary methyl 
supply. For example, when mice are fed a choline- and methionine-de-
ficient diet, the enrichment of the repression mark H3K9me2 decreases in 
the promoters of imprinted genes Igf2 and H19 in the prostate; however, 
the changes in H3K9me2 enrichment do not affect the imprinting of these 
two genes (Dobosy et al. 2008). In contrast, feeding a methyl-deficient diet 
increases the abundance of H3K9me3 and the expression of the Suv39h1 
methyltransferase in preneoplastic nodules and liver tumors in rats com-
pared with controls on a normal diet (Pogribny et al. 2006). It is possible 
that these apparently contradictory observations are caused by locus-spe-
cific effects, by epigenomic synergies with other epigenetic marks, or by a 
combination of both mechanisms.
Distinct H3K9, H3K27, and H4K20 methylation marks are enriched across 
tandem repeats (e.g., major and minor satellites), DNA transposons, retrotrans-
posons, long interspersed nucleotide elements, and short interspersed nucleo-
tide elements in the mouse genome (Martens et al. 2005). Evidence that epigen-
etic mechanisms are important in retroelement control and cancer prevention 
are as follows (Chen et al. 1997; Chen and Townes 2000; Chew et al. 2008; 
Jahner et al. 1982; Slotkin and Martienssen 2007; Walsh et al. 1998; Yoder et al. 
1997): Firstly, the human genome contains at least 54 transcriptionally active 
LTRs (Buzdin et al. 2006). Retrotransposons and any integrating virus produces 
DNA breaks during integration (Gasior et al. 2006) that may directly or indi-
rectly lead to tumorigenesis (Fan 2007). Secondly, retrotransposition events ac-
count for ~10 % of known spontaneous mutations in mice (Kazazian and Mo-
ran 1998; Smit 1999). Thirdly, retroelements are associated with break-prone 
segmental duplications in tumors (Darai-Ramqvist et al. 2008). Finally, chro-
mosomal instability caused by aberrant epigenetic marks and the insertion of 
retrotransposons lead to oncogene activation, tumor suppressor gene inactiva-
tion, and the disruption of essential genes (Check 2003; Eden et al. 2003; Fein-
berg and Tycko 2004).
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4 Biotinylation of Histones
Biotinylation of histones is a novel epigenetic mark that was discovered 
in the Zempleni laboratory (Bao et al. 2011a; Camporeale et al. 2004; Chew et 
al. 2006; Kobza et al. 2005; Kobza et al. 2008; Stanley et al. 2001) and subse-
quently confirmed by two independent laboratories (Bailey et al. 2008; Ghosh 
2009). To date, 12 distinct biotinylation sites have been identified in histones 
(Figure 2), and all known species of biotinylated histones are gene repression 
marks (Camporeale et al. 2007a; Chew et al. 2008; Gralla et al. 2008; Pestinger et 
al. 2011). Biotinylation marks appear to be more abundant in histones H3 and 
H4 than in other histones. Evidence suggests that nucleosomal condensation 
increases in response to biotinylation of K12 and possibly other target sites in 
histone H4 (Filenko et al. 2011).
Holocarboxylase synthetase (HLCS) plays a pivotal role in covalently link-
ing biotin to histones (Bao et al. 2011a; Camporeale et al. 2006, 2007; Kobza et 
al. 2008). Consistent with the important roles of HLCS in epigenomics, no liv-
ing HLCS null individual has ever been reported, indicating this condition may 
cause embryonic lethality. HLCS knockdown studies (~30 % residual activity) 
produced phenotypes such as decreased life span and heat resistance in Dro-
sophila melanogaster (Camporeale et al. 2006), and aberrant gene regulation in 
human cell lines (Chew et al. 2008; Gralla et al. 2008; Pestinger et al. 2011). Mu-
tations have been identified and characterized in the human HLCS gene. These 
mutations cause a substantial decrease in HLCS activity and metabolic abnor-
malities (National 2008; Suzuki et al. 2005). Unless diagnosed and treated early, 
HLCS deficiency appears to be uniformly fatal (Thuy et al. 1999).
HLCS is present in both nuclear and extranuclear structures (Chew et al. 
2006; Narang et al. 2004). Nuclear HLCS is a chromatin protein (Camporeale et 
al. 2006); its binding to chromatin is mediated by physical interactions with his-
tones H3 and H4 (Bao et al. 2011a). Our knowledge of HLCS regulation consists 
Figure 2. Modifica-
tions in histones H2A, 
H3, and H4. Biotinyl-
ation sites in histone 
H2B are unknown.  
Abbreviations: Ac 
acetate, B biotin, 
M methyl, P phos-
phate, U ubiqui-
tin. “?” = awaits 
confirmation.
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of the following: (a) Both the abundance of HLCS mRNA and the nuclear trans-
location of HLCS depend on biotin (Gralla et al. 2008). (b) The human HLCS 
promoter has been tentatively identified (Warnatz et al. 2010) but not yet charac-
terized in great detail. (c) The expression of HLCS is repressed by miR-539 (Bao 
et al. 2010). (d) HLCS-dependent histone biotinylation cross talks with cytosine 
methylation in gene regulation. When cytosine methylation marks are erased by 
treatment with 5-aza-2’-deoxycytidine, the expression of HLCS decreases com-
pared with untreated controls. The effects of 5-aza-2’-deoxycytidine on HLCS 
expression are partly mediated by cytosine demethylation of the promoters in 
the two human miR-153 genes, leading to high levels of miR-153 and, subse-
quently, miR-153-dependent degradation of HLCS mRNA (Bao et al. 2011b).
The binding of biotin to histones is a reversible process, but the identity of 
the histone debiotinylase is uncertain. Circumstantial evidence indicates that 
biotinidase has histone debiotinidase activity (Ballard et al. 2002; Chew et al. 
2007). Biotinidase has histone biotinyl transferase activity in vitro (Camporeale 
et al. 2004; Hymes et al. 1995), but HLCS appears to be more important than bi-
otinidase for catalyzing histone biotinylation in vivo (Camporeale et al. 2006). 
Presumably, the histone transferase activity of biotinidase is an artifact caused 
by artificially high concentrations of the biotin donor biotin-ε-lysine in vitro, 
thereby shifting the reaction equilibrium toward biotinylation of histones.
Histone biotinylation is a comparably rare event in human tissues (i.e., 
<0.001 % of histones are biotinylated) (Bailey et al. 2008; Kuroishi et al. 2011; 
Stanley et al. 2001); however, the abundance of an epigenetic mark is not an in-
dicator of biological importance. For example, serine-14 phosphorylation in his-
tone H2B and histone poly(ADP-ribosylation) are detectable only after induc-
tion of apoptosis and major DNA damage, respectively, but the role of these 
epigenetic marks in cell death is unambiguous (Boulikas 1988, 1989; Cheung et 
al. 2003). The abundance of histone biotinylation marks is much greater in con-
fined genomic loci compared with bulk histones. For example, about one out 
of three molecules of histone H4 is biotinylated at K12 (Wijeratne et al. 2010). 
Please note that about 50 % of the histones are biotinylated in Candida albicans 
chromatin (Ghosh 2009).
While the abundance of biotinylated proteins depends on biotin supply in 
adults (Chew et al. 2008; Stratton et al. 2006) and human cell cultures (Camp-
oreale et al. 2007a; Chew et al. 2008; Gralla et al. 2008; Pestinger et al. 2011), 
human biotin requirements are still unknown (National 1998). Depletion of 
histone biotinylation causes deregulation of genes (Camporeale et al. 2007b; 
Gralla et al. 2008; Pestinger et al. 2011). The production of viral particles, the 
frequency of retrotransposition events, and the number of chromosomal ab-
normalities increase when long terminal repeats are derepressed by biotin de-
pletion or HLCS knockdown in cell cultures, humans, and Drosophila (Chew 
et al. 2008). Retrotransposition events can also cause cancer (Check 2003; Da-
rai-Ramqvist et al. 2008; Eden et al. 2003; Fan 2007; Feinberg and Tycko 2004; 
Kazazian and Moran 1998; Smit 1999). Thus, biotin deficiency may be a risk 
factor for cancer formation. Recently, we have proposed an alternative model 
to explain the roles of biotin in epigenetic mechanisms of gene regulation 
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(Kuroishi et al. 2011). According to that model, biotin regulates the assembly of 
a HLCS-containing multiprotein gene repression complex. This protein com-
plex mediates gene repression through histone methylation and histone deacet-
ylation events, whereas histone biotinylation is a mere side product created by 
this complex with no meaningful biological functions.
It is now widely appreciated that nutrients may have synergistic effects in 
gene regulation by epigenomic mechanisms. For example, while folate defi-
ciency alone is typically insufficient to impair gene regulation, a combined defi-
ciency of folate and other methyl donors can have detrimental effects for health 
(Christman 2003; Cooney 2008, 2009; Kirkland et al. 2007; Wolff et al. 1998). Ev-
idence also demonstrates the existence of cross talk among biotinylation and 
methylation marks in maintaining genome stability (Camporeale et al. 2007a; 
Chew et al. 2008; Gralla et al. 2008; Pestinger et al. 2011). Specifically, we re-
ported that histone biotinylation is substantially impaired when cytosine meth-
ylation marks are erased by treating cells with 5-aza-2’-deoxycytidine but that 
the depletion of histone biotinylation marks does not affect cytosine methyl-
ation (Chew et al. 2008). These previous studies suggest that biotinylation of 
histones depends on prior methylation of cytosines and that H3K9me2 marks 
cross talk with K12-biotinylated histone H4 (H4K12bio) in the repression of 
long terminal repeats (Figure 3).
Derepression of retroelements by biotin depletion and HLCS deficiency un-
ambiguously links biotin status with cancer risk; however, the causal links be-
tween histone biotinylation and the teratogenic effects of biotin deficiency re-
main to be demonstrated (Mock 2009; Watanabe 1983). The human requirement 
for biotin is unknown (National 1998). Thus, only recommendations for Ade-
quate Intake are available for biotin. These recommendations are based solely 
on the intake of biotin in the general, apparently healthy, population (National 
1998). This approach is flawed in the case of biotin where dietary intake data 
are only crude estimates. Currently, no studies are available that quantified bi-
otin in foods by using chemically specific assays (Zempleni and Mock 2000), 
and it is unclear whether intake estimates exceed or underestimate the true bi-
otin intake. Also, the “normal state” is defined by using biotin-dependent car-
boxylases or urinary metabolites as markers while ignoring the apparently sub-
tle changes occurring at the chromatin level.
Figure 3. Epigenomic synergies between diet-dependent methylation and bioti-
nylation events. Abbreviations: DNMT1 DNA methyltransferase 1, EHMT-1 eu-
chromatic histone methyltransferase, H3K9me2 K9-dimethylated histone H3, 
H4K12bio K12-biotinylated histone H4, HLCS holocarboxylase synthetase, 
MeCP2 methyl-CpG-binding domain protein 2.
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5 Poly(ADP-ribosylation) of Histones
All five major classes of histones are targets for poly(ADP-ribosylation), but 
the mark is more abundant in histones H1 and H2B than in other classes (Bou-
likas et al. 1990; Kim et al. 2005). Lysine residues in histones are among the 
prime poly(ADP-ribosylation) sites (Messner et al. 2010). Poly(ADP-ribosyl-
ation) of histones is catalyzed by poly(ADP-ribose) polymerase and depends 
on nicotinamide adenine dinucleotide (NAD+) as ADP-ribose donor; nicotin-
amide is released in this reaction (Figure 4). Poly(ADP-ribosylation) is char-
acterized by the binding of multiple subunits of ADP-ribose. Branching of 
the poly(ADP-ribose) chains may occur every 30–50 residues and involves ri-
bose-ribose 1” → 2’ bonds (Kim et al. 2005; Miwa et al. 1981). The abundance of 
poly(ADP-ribosylation) marks is low in normal cells but can increase substan-
tially in response to treatment with mitogens and DNA damaging agents (Bou-
likas 1988; Boulikas et al. 1990). It has been suggested that poly(ADP-ribosyl-
ated) histones are intermediates in nuclear processes that involve DNA strand 
breaks including repair, replication, and recombination (Boulikas 1990; Bou-
likas et al. 1990; Kim et al. 2005; Malanga and Althaus 2005). It is speculated 
that poly(ADP-ribose) can induce free DNA domains by removing histones 
from specific nucleosomes whose DNA has been damaged (Boulikas 1993). The 
massive negative charge introduced by poly(ADP-ribosylation) might play a 
role in histone removal. Poly(ADP-ribosylation) of histones is a reversible pro-
cess; ADP-ribose residues are removed by poly(ADP-ribose) glycohydrolase 
(Miwa et al. 1981).
The water-soluble vitamin niacin (as nicotinamide) is an essential building 
block of NAD+, and poly(ADP-ribosylation) of histones depends on niacin sup-
ply. Please note that NAD+ can also be derived from dietary sources other than 
Figure 4. Chemical 
structure of nicotinamide 
adenine dinucleotide.
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niacin. Humans can convert the essential amino acid L-tryptophan to niacin 
(National 1998), and trigonelline can be demethylated to produce nicotinic acid, 
which is a bioactive niacin derivative (Figure 5). Coffee is a good source of trig-
onelline, and it can contribute meaningful quantities of niacin to the daily intake 
(Casal et al. 2000). Niacin deficiency is rare in Western societies, but might be 
observed in societies where most of the dietary niacin comes from plant-based 
foods. In plants, most of the niacin is present as nicotinic acid esters with vari-
ous macromolecules, which have a low bioavailability (Mason et al. 1973). Nic-
otinic acid can be released by alkaline treatment during cooking such as during 
preparation of corn-based tortillas. There are no published reports linking di-
etary niacin with the cellular response of DNA strand breaks in humans.
6 Ubiquitination and Sumoylation of Histones
Ubiquitin is a 76-amino acid protein that is covalently attached to K119 in 
histone H2A and K120 in histone H2B via an isopeptide bond with G76 in ubiq-
uitin (Zhang 2003). About 5–15 % and 1–2 % of histones H2A and H2B, respec-
tively, are ubiquitinated (Robzyk et al. 2000; West and Bonner 1980). Histones 
H3 and H1 are also targets for ubiquitination, but the abundance of ubiquiti-
nation marks in these histones is low (Chen et al. 1998; Pham and Sauer 2000). 
Ubiquitination of histone H2B is catalyzed by Rad6 (or its mammalian ortho-
logs HR6A and HR6B) and Bre1 (or its human orthologs) (Hwang et al. 2003; 
Koken et al. 1991; Pickart 2001). The enzymes responsible for the ubiquitina-
tion of histone H2A have not yet been identified. Apparently, TAFII250 plays a 
role in the ubiquitination of histone H1 (Pham and Sauer 2000). At least four ly-
sine residues in ubiquitin (i.e., K11, K29, K48, and K63) can serve as attachment 
sites for additional ubiquitin molecules, thereby creating polyubiquitin chains 
(Pickart 2001). The majority of ubiquitinated histone H2A is monoubiquiti-
nated, but polyubiquitinated H2A has also been detected (Nickel et al. 1989). 
In contrast, no polyubiquitinated histone H2B has been reported to date. Deu-
biquitination of histones is catalyzed by isopeptidases such as Ubp8 (Henry et 
al. 2003; Wilkinson 2000); at least 19 histone deubiquitinases have been identi-
fied in yeast (DAndrea and Pellman 1998). Sequential ubiquitination and deu-
biquitination are both involved in transcriptional activation in a process that is 
mediated by methylation of K4, K36, and K79 in histone H3 (Briggs et al. 2002).
Figure 5. Chemical 
structures of nicotinamide, 
nicotinic acid, and 
trigonelline.
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Histones are also modified by covalent binding of small ubiquitin-like mod-
ifier (SUMO) proteins. SUMO shares 18 % identity with ubiquitin and has a 
similar 3D structure (Melchior 2000). Sumoylation of lysine residues in histones 
is mediated by the ubiquitin-like protein SUMO-1 conjugating enzyme, UBC9, 
and it plays a role in gene repression. Sumoylation marks can be removed en-
zymatically by ULP-related proteases (Nathan et al. 2003).
As of today, there are no published reports linking nutrient intake to aber-
rant patterns of histone ubiquitination and sumoylation. Theoretically, one can 
envision scenarios where impaired protein synthesis in cells might affect ubiq-
uitination and sumoylation, but this is pure speculation.
7 Conclusions
While the link between diet and epigenetic mechanisms is most apparent 
for dietary methyl donors (e.g., folate, choline, and betaine) (Kouzarides and 
Berger 2007; Li and Bird 2007), it is now widely appreciated that other dietary 
molecules also modify the epigenome. Examples include the biotin-dependent 
assembly of gene repression complexes (Kuroishi et al. 2011), the pantothenic 
acid-dependent generation of acetyl-CoA (Garrett and Grisham 1995) as a sub-
strate for acetylation of histones, the curcumin-dependent inhibition of histone 
acetyl transferases (Morimoto et al. 2008), the niacin-dependent deacetylation 
of histones by class III histone deacetylases (HDACs) (Boily et al. 2008; Dok-
manovic et al. 2007), the butyrate- and sulforaphane-dependent inhibition of 
HDACs (Cummings et al. 2001; Davie 2003; Ho et al. 2009; Myzak et al. 2006), 
the iron-, riboflavin-, and calcium-dependent demethylation of histones (Tsu-
kada et al. 2006; Wang et al. 2004, 2009), and the niacin-dependent poly(ADP 
phosphorylation) of histones (Boulikas et al. 1990; Kim et al. 2005; Messner et 
al. 2010). Nutrient-dependent modification of the epigenome is an exciting field 
of research, because diet is the one environmental factor that the entire popula-
tion is exposed to on a daily basis during all stages of life, and where exposure 
can be modified by lifestyle choices.
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